Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
Authors:
- A BasuA Basu
- R H GlewRGR H Glew
- L B DanielsLDL B Daniels
- L S ClarkLCL S Clark
Open Access
- 1 February 1984
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 259 (3) , 1714-1719
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Comparison of various β-glucosidase assays used to diagnose gaucher's diseaseClinica Chimica Acta, 1980
- Destruction and resynthesis of mouse β-glucosidasesBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Acute neuropathic Gaucher disease in a black infantThe Journal of Pediatrics, 1978
- Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.Proceedings of the National Academy of Sciences, 1978
- THE GAUCHER MOUSE: DIFFERENTIAL ACTION OF CONDURITOL B EPOXIDE AND REVERSIBILITY OF ITS EFFECTSJournal of Neurochemistry, 1978
- Synthetic substrate ß‐glucosidase activity in leukocytes: A reproducible method for the identification of patients and carriers of Gaucher's diseaseClinical Genetics, 1978
- Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.Proceedings of the National Academy of Sciences, 1977
- Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.Journal of Biological Chemistry, 1977
- Differentiation of β-glucocerebrosidase from β-glucosidase in human tissues using sodium taurocholateArchives of Biochemistry and Biophysics, 1976
- Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activityBiochemical and Biophysical Research Communications, 1976